Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Research

Abstracts: 2013 PH Professional Network Symposium

The Power of Teamwork: 10 Years of Professional Collaboration in PAH

 

  1. Tadalafil Efficacy and Safety in Pulmonary Hypertension Patients with Elevated Pulmonary Capillary Wedge Pressure: A. Agarwal; R. Ramakrishna; R. Benavides; G. Ferrer; J. Ramirez; A.Hadeh; E. Oliveira; L. Smolley; J. Mehta; F. Rahaghi
  2. Subcutaneous to Intravenous Prostacyclin Analogue Transition in Pulmonary Hypertension: L. Alkukhun, MD; N. Bair CNS-BC; R. Dweik, MD; A. Tonelli, M
  3. Implementation of an Automatic Pharmacy Consult Process for Continuous Infusion Prostacyclin Orders: R. Anderson, PharmD, BCPS; M. Fox, PharmD, BCPS
  4. Rationale and Study Design of SYMPHONY: A Validation Trial forthe PAH-SYMPACT™, A PAH-Specific Patient-Reported Outcome Instrument: D. Badesch; R. Channick; K. Chin; A. Fischer; R. Frantz; C. Miller; E.Hunsche; A. Conrad; R. Zamanian
  5. Epoprostenol Dosing Regimens in the PROSPECT Registry: M. Chakinala, MD; R. Barst, MD; R. Frantz, MD; A. Frost, MD; D.Miller, MS; R. Schilz, DO, PhD; B. Hartline, MD; W. Benton, PharmD; H.Palevsky, MD; H. Farber, MD
  6. Macitentan Reduces PAH-Related Hospitalizations: Results from the Randomized Controlled SERAPHIN Trial: R. Channick; M. Delcroix; N. Galiè; H. Ghofrani; E. Hunsche; P. Jansa; F.Le Brun; S. Mehta; C. Mittelholzer; L. Perchenet; T. Pulido; B. Sastry; O.Sitbon; R. Souza; A. Torbicki; L. Rubin; G. Simonneau
  7. Systemic Sclerosis: Influence of Vasodilator Therapy for Treatment of Digital Ulcers on Pulmonary Vascular Disease Progression and Overall Survival: M. Cheli; L. Baldi Caproriti; I. Rota; F. Spanò; F. Puppo; G. Bezante; C.Brunelli; M. Balbi
  8. Characterization of Patients Enrolled in RESPIRE, The Registry to Prospectively Evaluate Use of Ventavis® in Patients with Pulmonary Arterial Hypertension: C. Daniels, MD; S. Studer, MD, MS; F. Rahaghi, MD; J. McConnell,MD; J. Elwing, MD, FCCP; J. Sager, MD, MSCE, FCCP; R. Zolty, MD; S.Petersen, MS; S. Short, MPH; D. Villanueva, MD; W. Benton, PharmD; N.Kim, MD
  9. Implementation of a Pharmacist Education and Competency Program: M. Fox, PharmD, BCPS; R. Anderson, PharmD, BCPS
  10. Bloodstream Infection Rates in Patients with Pulmonary Arterial Hypertension Treated with Epoprostenol for Injection (Veletri®): A Prospect Registry Analysis: R. Frantz, MD; M. Chakinala, MD; R. Barst, MD; R. Schilz, DO, PhD;K. Chin, MD; A. Hemnes, MD; D. Miller, MS; W. Benton, PharmD; B.Hartline, MD; H. Farber, MD
  11. Patient Communication Expectations Post-Research Study ParticipationM. Gray
  12. Safety, Tolerability, and Efficacy of Rapid Inpatient Titration ofIntravenous Treprostinil for Pulmonary Arterial Hypertension: L. Hansen, RN, MS, MEd; F. Rischard, DO, MS; S. Knoper, MD
  13. Quick Competence and Educational Plan for a New PH Program: A. Hawthorne, MS, RN-BC, CPN; P. Lawrence, MSN, RN, CPNP; C. Davis,MSN, RN; L. Mastin, BSN, RN, CPN; C. Winn BSN, RN
  14. Predictors of Persistence in Patients with Pulmonary Arterial Hypertension (PAH) Enrolled in the RESPIRE Registry: N. Kim, MD; F. Rahaghi, MD; J. Elwing, MD; J. Sager, MD; K. Chin,MD; Z. Safdar, MD; D. Ross, MD; S. Short, MPH; D. Villaneuva, MD; W.Benton, PharmD; C. Daniels, MD
  15. Effort Dependence of Change in 6 Minute Walk Test in Pulmonary Hypertension Was Improved by Correction with the Change in Heart Rate: Defining a New Composite Measure, the Beat Yield: A. Kumar; M. Hernandez; S. Talebi; Royya; R. Benavides; J. Mehta; F.Rahaghi
  16. Characteristics of Systemic Sclerosis Patients with Pulmonary Hypertension and a Pulmonary Capillary Wedge Pressure >15 in the PHAROS (Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma) Registry: M. Lammi, MD; L. Saketkoo, MD, MPH; J. Gordon, MD, MSc; P. Lauto,RN, BSN, CCRN; V. Steen, MD
  17. Creating a Comprehensive IV Prostanoid Policy: Challenges and Lessons Learned from a New Pediatric PH Program: P. Lawrence, MSN, RN, CPNP-AC/PC; U. Kanaan, MD; A. Hawthorne,MS, RN-BC, CPN; J. Cecil, BSN, RN, CPN; G. Clarendon, MS, RN, CRRN,CNRN; C. Davis, MSN-Ed, BSN, BS, CCRN; L. Montegna, PharmD; L.Rogers-Streck, RN, BSN, CPHRM; C. Watson Winn, RN, BSN
  18. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) Questionaire: A New Disease-SpecificPatient-Reported Outcome Instrument for PAHDMcCollister, RN, BSN; S. Kummer Shaffer, BA; D. Badesch, MD; A.Filusch, MD; E. Hunsche, PhD; R. Schüler, MSc; I. Wiklund, PhD; A.Peacock, MD
  19. Pulmonary Arterial Hypertension (PAH) has a Global Impact on Patients & Caregivers: Results from US Population Based Qualitative Interviewsand Quantitative Surveys: D. McCollister; R. Aldrighetti; H. Chen; M. Mullen; M. Park; S. Lombardi;A. Fischer; S. Studer
  20. Macitentan Improves Health-Related Quality of Life in Pulmonary Arterial Hypertension: Results from the Randomized Controlled SERAPHIN Trial: S. Mehta; R. Channick; M. Delcroix; N. Galiè; H. Ghofrani; E. Hunsche; P.Jansa; F. Le Brun; C. Mittelholzer; L. Perchenet; T. Pulido; B. Sastry; R.Souza; O. Sitbon; A. Torbicki; L. Rubin; G. Simonneau
  21. Use of Heated High Flow Nasal Cannula (HHFNC) Therapy to Maintain Oxygenation During Vasoreactivity (VR) Testing with Nitric Oxide (NO) for Assessing Pulmonary Hypertension (PH): J. Murphy, MS, RRT, CPFT; F. Lucas, BS, RRT; C. Turner, MD
  22. Retrospective Observational Study of Pulmonary Hypertension Patients Dosed with Greater than 9 Breaths qid of Inhaled Treprostinil: A. Poms; S. McNeilly; T. Fortin, MD; V. Tapson, MD
  23. An Emerging Language For Pulmonary Hypertension within The World Health Organization’s (WHO) International Classification Of Functioning,Disability and Health (ICF): L. Saketkoo; G. Yandle; H. Grewal; J. Erbil; P. Lauto; R. Escorpizo;K. Keen; M. Lammi; M. Heenan; T. Wilson; A. Harvey-McKee; F. Smart;B. DeBoisblanc; O. Distler
  24. Fatigue May Parallel Dyspnea in Impact on Functioning and Quality of Life in Patients with Pulmonary Hypertension: L. Saketkoo, MD, MPH; H. Grewal, MD; J. Erbil, MD; G. Yandle, MD, RN;M. Lammi, MD; P. Lauto, RN; A. Harvey-McKee; M. Heenan; T. Wilson; F.Smart; O. Distler; B. DeBoisblanc
  25. What Patients with Newly Diagnosed Pulmonary Hypertension Want to Hear from Physicians: A Desire for Honest, Clear and Hopeful Communication with Concern for Need of Improved Physician Education L. Saketkoo; J. Erbil, MD; H. Grewal, MD; G. Yandle, MD, RN; P. Lauto,RN; T. Wilson; M. Heenan; A. Harvey-McKee; F. Smart; O. Distler; B.DeBoisblanc; M. Lammi MD
  26. PROSPECT Patient Subgroups and Etiologies: Predictors of Outcome: R. Schilz, DO, PhD; D. Badesch, MD; R. Barst, MD; M. Chakinala, MD;R. Frantz, MD; D. Miller, MS; B. Hartline, MD; W. Benton, PharmD; V.McLaughlin, MD; H. Farber, MD
  27. Patient Satisfaction Quality Project: Reduction of Total Time Spent in Clinic for Interstitial Lung Disease and Pulmonary Hypertension Patients: L. Scott, PhD, RN, CHFN; E. Isaly, BA; Q. Berryman; D. Brooks-Ferguson,BS; A. Boronow, BSN, RN, CHFN, CCTC; A. Gardner, BSN, RN; J.Rappold, BSN,RN; J. Phelp
  28. A Predictive Model of the Effects of Depression, Anxiety, Stress, Six Minute Walk Distance, and Social Support on Health Related Quality of Life in the Adult Pulmonary Hypertension Population: T. Tartavoulle MN, RN, CNS
  29. Initiation and Titration of IV Treprostinil Using CRONO-5 Pump: G. Traiger, RN, MSN, CNS-BC; K. McCloy, RN, MSN, ACNP
  30. A ‘Virtual’ Echocardiographic Score for Predicting the Hemodynamic Profile in Pulmonary Hypertension: A. Vaidya, MD; A. Opotowsky, MD; P. Forfia, MD
  31. Factors Associated with Adherence to Phosphodiesterase Type 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension: A. Waxman, MD, PhD; S. Chen, PhD; L. Boulanger, MA, MBA; J. Watson,PharmD; G. Golden, MD, PhD
  32. Description of Inpatient Prostacyclin Infusion Pump Usage: A Multi-Hospital Survey: M. Wilson, ARNP
  33. Submaximal Exercise Testing for Pulmonary Arterial Hypertension: Utilization of New Technology: T. Zeiger, RRT; J. Neal; A. Lee; C. Burger, MD

2013 Symposium Thumbnail Medium